metricas
covid
Buscar en
Revista Española de Cirugía Ortopédica y Traumatología
Toda la web
Inicio Revista Española de Cirugía Ortopédica y Traumatología The role of minimally invasive spine surgery in the treatment of vertebral meta...
Información de la revista
Vol. 67. Núm. 6.
Páginas S458-S462 (noviembre - diciembre 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
603
Vol. 67. Núm. 6.
Páginas S458-S462 (noviembre - diciembre 2023)
Spinal monograph
Acceso a texto completo
The role of minimally invasive spine surgery in the treatment of vertebral metastasis: A narrative review
El papel de la cirugía mínimamente invasiva de columna en el tratamiento de las metástasis vertebrales: una revisión narrativa
Visitas
603
D. Garríguez-Péreza,
Autor para correspondencia
danielgarriguez@gmail.com

Corresponding author.
, A. Vargas Jiménezb, R. Luque Péreza,c, A. Carrascosa Granadab, D. Oñate Martínez-Olascoagaa, J.L. Pérez Gonzáleza, I. Domínguez Estebana, F. Marcoa,c
a Unidad de Columna, Servicio de Cirugía Ortopédica y Traumatología, Hospital Clínico San Carlos, Madrid, Spain
b Servicio de Neurocirugía, Hospital Clínico San Carlos, Madrid, Spain
c Departamento de Cirugía, Universidad Complutense, Madrid, Spain
Contenido relacionado
D. Garríguez-Pérez, A. Vargas Jiménez, R. Luque Pérez, A. Carrascosa Granada, D. Oñate Martínez-Olascoaga, J.L. Pérez González, I. Domínguez Esteban, F. Marco
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Abstract
Background

Spinal metastases are a very common problem which dramatically affects the quality of life of cancer patients. The objective of this review is to address the issue of how minimally invasive surgery can play an important role in treating this pathology.

Methods

A literature review was performed, searching in the Google Scholar, PubMed, Scopus and Cochrane databases. Relevant and quality papers published within the last 10 years were included in the review.

Results

After screening the 2184 initially identified registers, a total of 24 articles were included for review.

Conclusion

Minimally invasive spine surgery is specially convenient for fragile cancer patients with spinal metastases, because of its reduced comorbidity compared to conventional open surgery. Technological advances in surgery, such as navigation and robotics, improve accuracy and safety in this technique.

Keywords:
Minimally invasive surgery
Vertebral metastasis
MISS
MIS
Resumen
Introducción

Las metástasis vertebrales son un problema muy frecuente y asocian un deterioro importante de la calidad de vida en los pacientes oncológicos. El objetivo de esta revisión es determinar el encaje de las técnicas quirúrgicas mínimamente invasivas dentro del manejo de esta entidad.

Métodos

Se realizó una revisión bibliográfica en las bases de datos Google Scholar, PubMed, Scopus y Cochrane. Se revisaron los artículos publicados en los últimos 10 años que fueran de una relevancia y calidad adecuadas.

Resultados

Tras el cribado de los 2.184 trabajos identificados inicialmente en las distintas bases de datos, se incluyeron un total de 24 artículos en esta revisión.

Conclusión

La cirugía mínimamente invasiva de columna es especialmente útil en pacientes oncológicos frágiles con metástasis vertebrales por la reducida comorbilidad que presentan las técnicas que se engloban en ella en comparación con la de la cirugía abierta convencional. Los avances en tecnología aplicada a la cirugía, como la navegación y la robótica, mejoran la precisión y reducen las complicaciones de esta técnica.

Palabras clave:
Cirugía mínimamente invasiva
Metástasis vertebrales
MISS
MIS
Texto completo
Introduction

Bones are the most frequent site of metastasis and the spine is the most affected bony region: the spine alone is the third anatomical site most commonly affected by metastasis, after the lung and the liver.1 On rare occasions, surgery of a spine metastasis may aspire to become part of a curative treatment, when there is a single tumour associated with a primary tumour that is also resectable.2 In the remainder of cases, which is the great majority, our role as surgeons in the management of this condition is mainly pain relief and an improvement in the quality of life in cancer patients with disseminated cancer undergoing palliative care. For this reason, minimally invasive spine surgery techniques (known by their acronym MISS) are a fundamental alternative in treatment.3 The purpose of this review is to define the role of MISS and other associated techniques in the treatment of patients with vertebral metastasis.

Material and methods

A review in the databases of Google Scholar, PubMed, Scopus and the Cochrane Library in November 2022 was made to identify all scientific papers addressing the treatment of vertebral metastases by minimally invasive surgery. The search parameter used was: (minimally invasive OR minimally invasive surgery OR minimally invasive spine surgery OR minimal access OR mini-open) AND (vertebral metasta* OR spinal metasta* OR metastatic spine OR metastatic vertebra*) NOT case report. The resulting papers were included if they had been published within the last 10 years and the text was available in English or Spanish. Two independent reviewers filtered these papers according to their titles and abstracts to discard those irrelevant to the topic under review and accessed the full text of the selected studies. Only those studies that met the quality standard of evidence proposed by the Centre for Evidence Based Medicine (CEBM) of the University of Oxford4 were used to write this review.

Results

The initial bibliographic search found a total of 2184 articles among the databases consulted. This dropped to 1395 registers when only works in Spanish or English in the last 10 years were included. Once the duplicates had been eliminated, the articles screened for relevance and their evidence assessed for quality a total of 24 studies for review were selected (Fig. 1).

Figure 1.

Flow diagram of the study inclusion process in the review.

(0.47MB).
Discussion

The treatment of spine metastases is mainly conditioned by the combination of the patient's disease stage and the severity of their symptoms.5 In addition, the willingness of patients to accept intensive treatment is multifactorial and complex.6,7 It is essential that the treatment options proposed to these patients reflect respect for their decision-making autonomy and include the alternatives that best fit their preferences in terms of how they want to manage their disease.7 The quality of life of cancer patients in advanced stages of the disease can be severely conditioned by spinal metastatic involvement, so appropriate management is key in these delicate moments of life, forgetting the curative treatment approach and seeking to improve quality of life for as long as posible.8

MISS has developed over the last few decades and has become a comparable alternative to open procedures for the management of spinal instability and spinal cord compression in patients with metastatic spinal disease.9

The survival of patients with vertebral metastases is around 20% at 2 years.10 This survival is not determined by the vertebral extent of the disease and the procedures that can be performed on these metastatic implants are not curative, but are aimed at maintaining or improving quality of life.5,11,12 Most published studies have proposed that surgery should be considered in patients with a life expectancy of more than 3–6 months.11,13–15

Metastatic spinal lesions may present with different symptoms, mainly pain, fractures and neurological impairments derived from spinal cord compression.16 Spinal cord compression may present in up to 14% of patients with metastatic spinal disease and generally lead to untreatable pain which affects mobility and sphincter continence.14 Pain relief and the relief of neurological complications may be achieved through surgery, radiation or both, thereby increasing the patient's quality of life.15,17 The best results of surgery in combination with radiotherapy or surgery alone compared with radiotherapy alone have been supported by numerous studies17 and, surgery has consequently become a standard for all patients with symptomatic vertebral metastasis.

Overall, both MISS procedures and open surgery provide similar pain reduction. However, numerous studies have supported the claim that MISS approaches have overall clinical outcomes that are equal or somewhat more favourable.18 These techniques have less intraoperative bleeding, which is beneficial in terms of not destabilising these fragile patients and improving their postoperative outcomes, as less anaemisation results in fewer transfusions and shorter in-hospital stay after surgery.19 A systematic review by Pennington et al. supports these findings in relation to reduced blood loss and shorter hospital stay20: despite heterogeneity between studies, a shorter hospital stay was found in patients treated with MISS compared to those undergoing open surgery (8.7 vs. 14.7 days).

Another advantage of MISS is its role in reducing surgical site infection. In a meta-analysis, Lu et al. showed a significant reduction in infection rates (1% with MISS competed with 4% with open surgery) in patients treated for vertebral metastasis.21 Other studies have corroborated similar lower infection rates when using MISS, especially when compared with open surgery and this backs up its role as a significant tool for potentially reducing infection.22 Kwan et al. published a series of 50 patients with pathological metastatic vertebral fractures who underwent percutaneous fixation with pedicle screws that did not have a single case of postoperative infection or wound dehiscence, and demonstrated the improved wound healing that can be achieved with smaller incisions.23

MISS may also offer benefits in infection rates when radiotherapy is part of the treatment plan. Radiotherapy contributes to poor wound healing, leading to increased susceptibility to wound dehiscence and subsequent infection. Much higher infection rates have been reported when open spinal surgery is performed in conjunction with radiotherapy, but the use of MISS approaches may allow earlier initiation of radiotherapy than would be possible after open procedures.24

Considering the economic aspects, MISS could lead to a reduction in healthcare costs due to the associated reduced need for days of hospitalisation, transfusions, re-interventions, rehabilitation and pain management. In terms of survival, no differences have been found between patients treated by MISS and open surgery.25

Despite the advantages of MISS for metastatic spinal disease, there are some significant drawbacks, including the surgeon's learning curve, increased radiation exposure and imprecise instrumentation placement.26,27 Accuracy can be compromised, especially in stabilisation procedures, both by the limited visualisation afforded by the smaller approach and the potential for altered anatomy resulting from a metastatic implant. To alleviate these handicaps, technological advances have allowed the incorporation of techniques such as navigation and robotic-assisted surgery, which have great potential to reduce radiation risk and improve accuracy.28 Navigation technology surgery could be considered a well-established technique for the treatment of metastatic spinal disease, as numerous studies have evaluated its ability to mitigate the decreased visualisation inherent to MISS, as well as to reduce the radiation exposure of the equipment.

The use of robotics in spine surgery is a new addition, with potential applications in many aspects of spine surgery. Although robotic-assisted surgical technique is distinct from navigation in terms of instrumentation, in many respects it can be seen as an evolution of navigation surgery because it relies on pre-operative or intra-operative imaging and computer assistance.29,30 The main advantage of robotic surgery over navigation surgery is that it has the potential to eliminate human error. The use of robotic surgery in cases of spinal metastases has not yet been studied, but its use in MISS could be especially useful in cases with distorted anatomy. Several studies have evaluated the accuracy of pedicle screw placement and complication rates of robotic-assisted MISS compared to open surgery. Solomiichuk et al. found increased rates of perfect screw placement (67.2% vs. 63.6%) and acceptable placement (84.4% vs. 83.7%) with robotic, although these differences were not statistically significant.29

Conclusion

The use of MISS techniques in vertebral metastasis combines several advantages over the standard approaches: although they are equal to these in surgical time and number of instrumented levels, they have less bleeding, less need for transfusion and lower infection rates, without compromising the precision of instrumentation or increasing perioperative complications. In addition, in-hospital stay after surgery is shorter with MISS techniques and ambulation is earlier. In terms of survival, both approaches are similar.

It should be noted that these benefits may be especially desirable in these more fragile cancer patients, whose comorbidities often make them poor candidates for open procedures or put them at higher risk of complications associated with open surgery.

MISS surgery and its adjuncts (navigation and robotics) have the potential to improve treatment while reducing the risk of complications that can significantly affect the quality of life of these patients.

Level of evidence

Level of evidence iv.

Conflict of interests

The authors have no conflict of interests to declare.

Funding

The authors of this publication declare that they have not received any funding for the preparation and development of the work. The Sociedad Española de Cirugía Ortopédica y Traumatología has financed the expenses related to the open access publication of the article.

References
[1]
C. Ryan, K.C. Stoltzfus, S. Horn, H. Chen, A. Louie, E. Lehrer, et al.
Epidemiology of bone metastases.
[2]
N. Sundaresan, J.H. Galicich, J.M. Lane, M.S. Bains, P. McCormack.
Treatment of neoplastic epidural cord compression by vertebral body resection and stabilization.
J Neurosurg, 63 (1985), pp. 676-684
[3]
P.C. McAfee, S.R. Garfin, W.B. Rodgers, R.T. Allen, F. Phillips, C. Kim.
An attempt at clinically defining and assessing minimally invasive surgery compared with traditional “open” spinal surgery.
[4]
Critical appraisal tools—Centre for Evidence-Based Medicine (CEBM), University of Oxford. Available from: https://www.cebm.ox.ac.uk/resources/ebm-tools/critical-appraisal-tools [accessed 29.3.23].
[5]
S. Sohn, J. Kim, C.K. Chung, N.R. Lee, E. Park, U.K. Chang, et al.
A nationwide epidemiological study of newly diagnosed spine metastasis in the adult Korean population.
[6]
A. Shrestha, C. Martin, M. Burton, S. Walters, K. Collins, L. Wyld.
Quality of life versus length of life considerations in cancer patients: a systematic literature review.
Psychooncology, 28 (2019), pp. 1367-1380
[7]
N.J. Meropol, B.L. Egleston, J.S. Buzaglo, A.B. Benson, D. Cegala, M.A. Diefenbach, et al.
Cancer patient preferences for quality and length of life.
Cancer, 113 (2008), pp. 3459-3466
[8]
M.G. Nayak, A. George, M.S. Vidyasagar, S. Mathew, B.S. Nayak, Y.N. Shashidhara, et al.
Quality of life among cancer patients.
Indian J Palliat Care, 23 (2017), pp. 445-450
[9]
S.L. Zuckerman, I. Laufer, A. Sahgal, Y.J. Yamada, M.H. Schmidt, D. Chou, et al.
When less is more: the indications for MIS techniques and separation surgery in metastatic spine disease.
Spine (Phila Pa 1976), 41 (2016), pp. S246-S253
[10]
K. Bhanot, J. Widdifield, A. Huang, J.M. Paterson, D.B. Shultz, J. Finkelstein.
Survival after surgery for spinal metastases: a population-based study.
Can J Surg, 65 (2022), pp. E512-E518
[11]
S.B. Yang, W. Cho, U.K. Chang.
Analysis of prognostic factors relating to postoperative survival in spinal metastases.
J Korean Neurosurg Soc, 51 (2012), pp. 127-134
[12]
P. Vanek, O. Bradac, F. Trebicky, K. Saur, P. de Lacy, V. Benes.
Influence of the preoperative neurological status on survival after the surgical treatment of symptomatic spinal metastases with spinal cord compression.
Spine (Phila Pa 1976), 40 (2015), pp. 1824-1830
[13]
P.E. Kaloostian, A. Yurter, P.L. Zadnik, D.M. Sciubba, Z.L. Gokaslan.
Current paradigms for metastatic spinal disease: an evidence-based review.
Ann Surg Oncol, 21 (2014), pp. 248-262
[14]
D.M. Sciubba, C.R. Goodwin, A. Yurter, J. Derek, Z.L. Gokaslan, C. Fisher, et al.
A systematic review of clinical outcomes and prognostic factors for patients undergoing surgery for spinal metastases secondary to breast cancer.
Global Spine J, 6 (2016), pp. 482-496
[15]
P.L. Zadnik, L. Hwang, D.G. Ju, M.L. Groves, J. Sui, A. Yurter, et al.
Prolonged survival following aggressive treatment for metastatic breast cancer in the spine.
Clin Exp Metastasis, 31 (2014), pp. 47-55
[16]
I. Laufer, D.M. Sciubba, M. Madera, A. Bydon, T.J. Witham, Z.L. Gokaslan, et al.
Surgical management of metastatic spinal tumors.
Cancer Control, 19 (2012), pp. 122-128
[17]
Z.A. Smith, I. Yang, A. Gorgulho, D. Raphael, A.A. De Salles, L.T. Khoo.
Emerging techniques in the minimally invasive treatment and management of thoracic spine tumors.
J Neurooncol, 107 (2012), pp. 443-455
[18]
S. Vertuani, J. Nilsson, B. Borgman, G. Buseghin, C. Leonard, R. Assietti, et al.
A cost-effectiveness analysis of minimally invasive versus open surgery techniques for lumbar spinal fusion in Italy and the United Kingdom.
Value Health, 18 (2015), pp. 810-816
[19]
N. Hansen-Algenstaedt, M.K. Kwan, P. Algenstaedt, C.K. Chiu, L. Viezens, T.S. Chan, et al.
Comparison between minimally invasive surgery and conventional open surgery for patients with spinal metastasis: a prospective propensity score-matched study.
Spine (Phila Pa 1976), 42 (2017), pp. 789-797
[20]
Z. Pennington, A.K. Ahmed, C.A. Molina, J. Ehresman, I. Laufer, D.M. Sciubba.
Minimally invasive versus conventional spine surgery for vertebral metastases: a systematic review of the evidence.
Ann Transl Med, 6 (2018), pp. 103
[21]
V.M. Lu, M.A. Alvi, A. Goyal, P. Kerezoudis, M. Bydon.
The potential of minimally invasive surgery to treat metastatic spinal disease versus open surgery: a systematic review and meta-analysis.
World Neurosurg, 112 (2018), pp. e859-e868
[22]
J.S. Uribe, A.R. Deukmedjian.
Visceral, vascular, and wound complications following over 13,000 lateral interbody fusions: a survey study and literature review.
Eur Spine J, 24 (2015), pp. 386-396
[23]
M.K. Kwan, C.K. Lee, C.Y. Chan.
Minimally invasive spinal stabilization using fluoroscopic-guided percutaneous screws as a form of palliative surgery in patients with spinal metastasis.
Asian Spine J, 10 (2016), pp. 99-110
[24]
F. Zairi, A. Arikat, M. Allaoui, P. Marinho, R. Assaker.
Minimally invasive decompression and stabilization for the management of thoracolumbar spine metastasis.
J Neurosurg Spine, 17 (2012), pp. 19-23
[25]
S.Ø.S. Morgen, L.V. Hansen, T. Karbo, R. Svardal-Stelmer, M. Gehrchen, B. Dahl.
Minimal access vs open spine surgery in patients with metastatic spinal cord compression: an one-center randomized controlled trial.
Anticancer Res, 40 (2020), pp. 5673-5678
[26]
S. Sharif, A. Afsar.
Learning curve and minimally invasive spine surgery.
World Neurosurg, 119 (2018), pp. 472-478
[27]
J.A. Sclafani, C.W. Kim.
Complications associated with the initial learning curve of minimally invasive spine surgery: a systematic review.
Clin Orthop Relat Res, 472 (2014), pp. 1711-1717
[28]
S. Virk, S. Qureshi.
Navigation in minimally invasive spine surgery.
J Spine Surg, 5 (2019), pp. S25-S30
[29]
V. Solomiichuk, J. Fleischhammer, G. Molliqaj, J. Warda, A. Alaid, K. von Eckardstein, et al.
Robotic versus fluoroscopy-guided pedicle screw insertion for metastatic spinal disease: a matched-cohort comparison.
Neurosurg Focus, 42 (2017), pp. E13
[30]
X. Hu, T.J. Scharschmidt, D.D. Ohnmeiss, I.H. Lieberman.
Robotic assisted surgeries for the treatment of spine tumors.
Int J Spine Surg, 9 (2015), pp. 1
Copyright © 2023. SECOT
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos